BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32529354)

  • 1. Correlation between Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Disease before and after Metabolic Bariatric Surgery.
    Zhang YX; Yang L; Yang CC; Wang WY; Shen JH; Shi ML; Yu Y; Dai QC; Gu Y; Yang JJ; Yu WW; Yao K; Hu M; Ni J; Sun JL; Zhang L; Sun HX; Lu XF; Wang B
    Obes Surg; 2020 Oct; 30(10):3803-3812. PubMed ID: 32529354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstructive Sleep Apnea and Non-alcoholic Fatty Liver Disease in Obese Patients Undergoing Bariatric Surgery.
    Schwenger KJP; Ghorbani Y; Li C; Fischer SE; Jackson TD; Okrainec A; Allard JP
    Obes Surg; 2020 Jul; 30(7):2572-2578. PubMed ID: 32124219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin Resistance, but Not Obstructive Sleep Apnea Is Associated with Hepatic Steatosis in Chinese Patients with Severe Obesity.
    Zhu C; Tang S; Xiao J; Zhang Y; Sun L; Zhang J; Ding L; Liu M
    Obes Facts; 2023; 16(4):344-355. PubMed ID: 36854279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of obstructive sleep apnea on nonalcoholic fatty liver disease in patients with severe obesity.
    Benotti P; Wood GC; Argyropoulos G; Pack A; Keenan BT; Gao X; Gerhard G; Still C
    Obesity (Silver Spring); 2016 Apr; 24(4):871-7. PubMed ID: 26880657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of obstructive sleep apnea on non-alcoholic fatty liver disease in patients with obesity: a systematic review.
    Hany M; Abouelnasr AA; Abdelkhalek MH; Ibrahim M; Aboelsoud MR; Hozien AI; Torensma B
    Int J Obes (Lond); 2023 Dec; 47(12):1200-1213. PubMed ID: 37696927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease associated with obstructive sleep apnea: just a coincidence?
    Daltro C; Cotrim HP; Alves E; de Freitas LA; Araújo L; Boente L; Leal R; Portugal T
    Obes Surg; 2010 Nov; 20(11):1536-43. PubMed ID: 20556538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between non-alcoholic fatty liver disease and obstructive sleep apnea.
    Umbro I; Fabiani V; Fabiani M; Angelico F; Del Ben M
    World J Gastroenterol; 2020 May; 26(20):2669-2681. PubMed ID: 32523319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea.
    Mesarwi OA; Shin MK; Drager LF; Bevans-Fonti S; Jun JC; Putcha N; Torbenson MS; Pedrosa RP; Lorenzi-Filho G; Steele KE; Schweitzer MA; Magnuson TH; Lidor AO; Schwartz AR; Polotsky VY
    Sleep; 2015 Oct; 38(10):1583-91. PubMed ID: 26085300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians.
    Bhatt SP; Guleria R; Vikram NK; Gupta AK
    Sleep Breath; 2019 Mar; 23(1):171-178. PubMed ID: 30032465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence and risk factors for fatty liver in Tunisian adults with obstructive sleep apnea].
    Maâlej S; Jedidi S; Hannachi H; Gharsalli H; Sahnoun I; Neji H; El Gharbi L
    Rev Mal Respir; 2020 Jan; 37(1):8-14. PubMed ID: 31899023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and associated factors of obstructive sleep apnea in morbidly obese patients undergoing bariatric surgery.
    Kositanurit W; Muntham D; Udomsawaengsup S; Chirakalwasan N
    Sleep Breath; 2018 Mar; 22(1):251-256. PubMed ID: 28396972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic intermittent hypoxia contributes to non-alcoholic steatohepatitis progression in patients with obesity.
    Fu Y; Zhang N; Tang W; Bi Y; Zhu D; Chu X; Shan X; Shen Y; Sun X; Feng W
    Hepatol Int; 2022 Aug; 16(4):824-834. PubMed ID: 35668285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic steatohepatitis in bariatric patients with a diagnosis of obstructive sleep apnea.
    Weingarten TN; Mantilla CB; Swain JM; Kendrick ML; Oberhansley JM; Burcham RJ; Ribeiro TC; Watt KD; Schroeder DR; Narr BJ; Sprung J
    Obes Facts; 2012; 5(4):587-96. PubMed ID: 22986647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of obstructive sleep apnea on fatty liver disease may be obscured by alcohol consumption: An ordinal logistic regression analysis.
    Zhang B; Lu S; Guo H; Xu J; Zhang X; Zhao H; Tang J
    Sleep Med; 2023 Sep; 109():82-89. PubMed ID: 37423023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between the Severity of Nocturnal Hypoxia in Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Damage.
    Cakmak E; Duksal F; Altinkaya E; Acibucu F; Dogan OT; Yonem O; Yilmaz A
    Hepat Mon; 2015 Nov; 15(11):e32655. PubMed ID: 26834793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score.
    Yeo SC; Ong WM; Cheng KSA; Tan CH
    Obes Surg; 2019 Apr; 29(4):1295-1300. PubMed ID: 30635812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Factors for Insufficient Weight Loss After Bariatric Surgery: Does Obstructive Sleep Apnea Influence Weight Loss?
    de Raaff CA; Coblijn UK; de Vries N; Heymans MW; van den Berg BT; van Tets WF; van Wagensveld BA
    Obes Surg; 2016 May; 26(5):1048-56. PubMed ID: 26220241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
    Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
    Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstructive sleep apnea and liver injury in severely obese patients with nonalcoholic fatty liver disease.
    Zhang L; Zhang X; Meng H; Li Y; Han T; Wang C
    Sleep Breath; 2020 Dec; 24(4):1515-1521. PubMed ID: 32002742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.
    Aron-Wisnewsky J; Minville C; Tordjman J; Lévy P; Bouillot JL; Basdevant A; Bedossa P; Clément K; Pépin JL
    J Hepatol; 2012 Jan; 56(1):225-33. PubMed ID: 21703181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.